Attached files
file | filename |
---|---|
EX-10.17.1 - EX-10.17.1 - Molecular Templates, Inc. | mtem-ex10171_735.htm |
EX-32.1 - EX-32.1 - Molecular Templates, Inc. | mtem-ex321_9.htm |
10-K - 10-K - Molecular Templates, Inc. | mtem-10k_20171231.htm |
EX-32.2 - EX-32.2 - Molecular Templates, Inc. | mtem-ex322_8.htm |
EX-31.2 - EX-31.2 - Molecular Templates, Inc. | mtem-ex312_10.htm |
EX-31.1 - EX-31.1 - Molecular Templates, Inc. | mtem-ex311_11.htm |
EX-23.2 - EX-23.2 - Molecular Templates, Inc. | mtem-ex232_570.htm |
EX-21.1 - EX-21.1 - Molecular Templates, Inc. | mtem-ex211_571.htm |
EX-10.23 - EX-10.23 - Molecular Templates, Inc. | mtem-ex1023_576.htm |
EX-10.22 - EX-10.22 - Molecular Templates, Inc. | mtem-ex1022_575.htm |
EX-10.17.2 - EX-10.17.2 - Molecular Templates, Inc. | mtem-ex10172_734.htm |
EX-10.11 - EX-10.11 - Molecular Templates, Inc. | mtem-ex1011_569.htm |
EX-10.8 - EX-10.8 - Molecular Templates, Inc. | mtem-ex108_574.htm |
EX-10.7 - EX-10.7 - Molecular Templates, Inc. | mtem-ex107_573.htm |
EX-4.3 - EX-4.3 - Molecular Templates, Inc. | mtem-ex43_572.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
1) |
Registration Statement (Form S-3 No. 333-220477) of Molecular Templates, Inc., |
|
2) |
Registration Statement (Form S-3 No. 333-207745) of Threshold Pharmaceuticals, Inc., |
|
3) |
Registration Statement (Form S-3 No. 333-202043) of Threshold Pharmaceuticals, Inc., |
|
4) |
Registration Statements (Form S-8 No. 333-221002) of Molecular Templates, Inc. pertaining to the 2009 Stock Plan, as amended, the 2014 Equity Incentive Plan, as amended, and the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
5) |
Registration Statements (Form S-8 No. 333-210089) of Threshold Pharmaceuticals, Inc. pertaining to the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
6) |
Registration Statements (Form S-8 No. 333-202476) of Threshold Pharmaceuticals, Inc. pertaining to the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
7) |
Registration Statements (Form S-8 No. 333-196249) of Threshold Pharmaceuticals, Inc. pertaining to the 2014 Equity Incentive Plan, and the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
8) |
Registration Statements (Form S-8 No. 333-187107) of Threshold Pharmaceuticals, Inc. pertaining to the 2004 Amended and Restated Equity Incentive Plan, and the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
9) |
Registration Statements (Form S-8 No. 333-180149) of Threshold Pharmaceuticals, Inc. pertaining to the 2004 Amended and Restated Equity Incentive Plan, and the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
10) |
Registration Statements (Form S-8 No. 333-173047 of Threshold Pharmaceuticals, Inc. pertaining to the 2004 Amended and Restated Equity Incentive Plan, and the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
11) |
Registration Statements (Form S-8 No. 333-167260) of Threshold Pharmaceuticals, Inc. pertaining to the Amended and Restated 2004 Equity Incentive Plan, |
|
12) |
Registration Statements (Form S-8 No. 333-164865) of Threshold Pharmaceuticals, Inc. pertaining to the 2004 Amended and Restated Equity Incentive Plan, and the Amended and Restated 2004 Employee Stock Purchase Plan, |
|
13) |
Registration Statements (Form S-8 No. 333-156733) of Threshold Pharmaceuticals, Inc. pertaining to the Amended and Restated 2004 Equity Incentive Plan, |
|
14) |
Registration Statements (Form S-8 No. 333-143130) of Threshold Pharmaceuticals, Inc. pertaining to the Amended and Restated 2004 Equity Incentive Plan, |
|
15) |
Registration Statements (Form S-8 No. 333-134598) of Threshold Pharmaceuticals, Inc. pertaining to the Amended and Restated 2004 Equity Incentive Plan, and the 2004 Employee Stock Purchase Plan, and |
|
16) |
Registration Statements (Form S-8 No. 333-126276) of Threshold Pharmaceuticals, Inc. pertaining to the 2001 Equity Incentive Plan, the 2004 Equity Incentive Plan, and the 2004 Employee Stock Purchase Plan; |
of our report dated March 30, 2018, with respect to the consolidated financial statements of Molecular Templates, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Austin, Texas
March 30, 2018